We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Ulcer Matrix Shown to Cure Skin Ulcers

By HospiMedica staff writers
Posted on 26 Dec 2000
A study being conducted on an investigational ulcer treatment shows that it is producing a high rate of cures for refractory diabetic and other types of severe skin ulcers. The 15 patients in the study had all failed previous therapy utilizing conventional methods.

The ulcer treatment, or ulcer matrix, was developed by LAM Pharmaceutical Corp. (Miami, FL, USA) and is based on new drug delivery technology involving an ionic polymer matrix (IPM) for the purpose of delivering, enhancing, and sustaining the action of therapeutic agents. The company expects to introduce the new ulcer matrix in 2001.

"The problem of slow-healing and nonhealing ulcers appears to becoming endemic. Factors contributing to the rise in the number of patients suffering from this serious condition appear to be related to an aging population and the ever-increasing number of infirm and bed-ridden patients,” said Alan Drizen, president and CEO of LAM.



Related Links:
LAM Pharmaceuticals

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Surgical Booms
AIRport
New
Carotid Artery Stent
Roadsaver

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization